Scarica l'app Stockscreener
2.47
0.82%
0.02
Precedente Chiudi:
$2.45
Aprire:
$2.46
Volume 24 ore:
376.59K
Relative Volume:
0.59
Capitalizzazione di mercato:
$174.71M
Reddito:
$299.48M
Utile/perdita netta:
$-86.45M
Rapporto P/E:
-1.6467
EPS:
-1.5
Flusso di cassa netto:
$-17.32M
1 W Prestazione:
+8.33%
1M Prestazione:
-5.36%
6M Prestazione:
-38.71%
1 anno Prestazione:
-66.44%
Intervallo 1D:
$2.365
$2.51
Intervallo di 1 settimana:
$2.23
$2.51
Portata 52W:
$2.015
$7.25
Health Catalyst Inc Stock (HCAT) Company Profile
Nome
Health Catalyst Inc
Settore
Industria
Telefono
801-708-6800
Indirizzo
10897 SOUTH RIVER FRONT PARKWAY, #300, SOUTH JORDAN
Confronta HCAT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HCAT
Health Catalyst Inc
|
2.47 | 173.29M | 299.48M | -86.45M | -17.32M | -1.50 |
|
VEEV
Veeva Systems Inc
|
240.12 | 39.64B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
66.27 | 12.16B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
43.79 | 8.23B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
94.15 | 8.42B | 1.15B | 96.70M | -161.99M | 1.09 |
|
BTSG
Brightspring Health Services Inc
|
37.53 | 7.05B | 11.99B | 24.18M | 234.31M | 0.2956 |
Health Catalyst Inc Stock (HCAT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-27 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2025-08-11 | Downgrade | Citigroup | Buy → Neutral |
| 2025-08-08 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2025-06-17 | Downgrade | BTIG Research | Buy → Neutral |
| 2025-04-09 | Downgrade | Evercore ISI | Outperform → In-line |
| 2025-01-08 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-04-10 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-01-03 | Iniziato | Barclays | Overweight |
| 2024-01-03 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2023-12-13 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2023-11-13 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2023-08-01 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-05-10 | Downgrade | Guggenheim | Buy → Neutral |
| 2023-05-10 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2023-04-20 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-04-12 | Iniziato | Stephens | Equal-Weight |
| 2023-04-04 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-01-03 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-10-31 | Iniziato | Wells Fargo | Equal Weight |
| 2022-10-25 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-09-16 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2022-09-13 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2022-08-05 | Downgrade | JP Morgan | Overweight → Neutral |
| 2022-08-05 | Downgrade | Stifel | Buy → Hold |
| 2022-04-14 | Iniziato | Guggenheim | Buy |
| 2022-03-17 | Aggiornamento | Jefferies | Hold → Buy |
| 2022-02-11 | Iniziato | Goldman | Buy |
| 2021-12-02 | Iniziato | Jefferies | Hold |
| 2021-10-14 | Iniziato | BTIG Research | Buy |
| 2021-04-29 | Ripresa | JP Morgan | Overweight |
| 2020-12-08 | Iniziato | Berenberg | Buy |
| 2020-07-14 | Iniziato | Citigroup | Buy |
| 2020-06-18 | Iniziato | Stifel | Buy |
| 2020-06-15 | Ripresa | Evercore ISI | Outperform |
| 2020-05-15 | Iniziato | Guggenheim | Buy |
| 2020-04-21 | Iniziato | RBC Capital Mkts | Outperform |
| 2020-04-13 | Iniziato | SVB Leerink | Outperform |
| 2020-04-02 | Iniziato | Canaccord Genuity | Buy |
| 2019-12-20 | Iniziato | Raymond James | Strong Buy |
| 2019-10-30 | Iniziato | Cantor Fitzgerald | Overweight |
| 2019-08-19 | Iniziato | Evercore ISI | Outperform |
| 2019-08-19 | Iniziato | Goldman | Buy |
| 2019-08-19 | Iniziato | JP Morgan | Overweight |
| 2019-08-19 | Iniziato | Piper Jaffray | Overweight |
| 2019-08-19 | Iniziato | SVB Leerink | Outperform |
| 2019-08-19 | Iniziato | SunTrust | Buy |
| 2019-08-19 | Iniziato | William Blair | Outperform |
Mostra tutto
Health Catalyst Inc Borsa (HCAT) Ultime notizie
Health Catalyst examines AI's tangible impact on healthcare - Traders Union
4 Analysts Have This To Say About Health Catalyst - Benzinga
HCAT: Citigroup Adjusts Price Target, Maintains Neutral Rating | - GuruFocus
Is Health Catalyst Inc. stock positioned well for digital economyWalking Comfort Picks & what to check before ordering - ulpravda.ru
Is Health Catalyst Inc. stock a top pick in earnings seasonJuly 2025 PreEarnings & Low Risk High Win Rate Picks - ulpravda.ru
How Health Catalyst Inc. stock compares to growth peers2025 Fundamental Recap & AI Powered Market Entry Strategies - ulpravda.ru
Can Health Catalyst Inc. stock rebound after recent weaknessMarket Rally & AI Driven Stock Movement Reports - ulpravda.ru
Is Health Catalyst Inc. stock a dividend growth opportunityJuly 2025 Action & Free Low Drawdown Momentum Trade Ideas - ulpravda.ru
Is Health Catalyst Inc. stock oversold or undervaluedMarket Risk Summary & Technical Pattern Alert System - ulpravda.ru
EPS Watch: Is Health Catalyst Inc stock positioned well for digital economy2025 Market Sentiment & Free Expert Approved Momentum Trade Ideas - moha.gov.vn
3 Russell 2000 Stocks Walking a Fine Line - Finviz
3 Value Stocks We Find Risky - Finviz
Stifel Nicolaus Reaffirms Their Hold Rating on Health Catalyst (HCAT) - The Globe and Mail
Signal Recap: Is Health Catalyst Inc stock oversold or undervaluedGap Down & Weekly High Return Stock Opportunities - moha.gov.vn
Investor Mood: Can Health Catalyst Inc stock rebound after recent weaknessWeekly Stock Analysis & Safe Entry Point Identification - moha.gov.vn
3 Stocks Under $10 We're Skeptical Of - Finviz
Health Catalyst, Inc. (NASDAQ:HCAT) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Bollinger Band Squeeze Points to Volatility in Winsome Textile Industries LimitedOptions Trading Strategies & Fast Profit Capital Growth - earlytimes.in
What analysts say about Health Catalyst Inc stockCandlestick Trading Patterns & Minimal Investment Profits - earlytimes.in
Health Catalyst Insider Ups Holding By 109% During Year - Yahoo Finance
Is Health Catalyst Inc. stock a buy before product launchesJuly 2025 Update & Weekly High Momentum Picks - Улправда
Health Catalyst, IncCommon stock (NQ: HCAT - FinancialContent
Will Health Catalyst Inc. (2YP) stock outperform global peersJuly 2025 Analyst Calls & Safe Capital Growth Stock Tips - Улправда
Why Health Catalyst Inc. stock is a must watch in 2025Market Performance Report & Momentum Based Trading Signals - Улправда
Death Cross: How Health Catalyst Inc. stock trades during market volatility2025 Market Outlook & Community Shared Stock Ideas - Улправда
Is Health Catalyst Inc. (2YP) stock attractive for growth fundsTrade Analysis Summary & Community Supported Trade Ideas - Улправда
HubSpot, nCino, Rapid7, and Health Catalyst Stocks Trade Down, What You Need To Know - Finviz
New Innovation Program to Strengthen Community Health Tech Economy in Northwest Arkansas - PR Newswire
Health Catalyst (NASDAQ:HCAT) General Counsel Benjamin Landry Sells 27,425 Shares - MarketBeat
Health Catalyst (NASDAQ:HCAT) Director Sells $128,151.99 in Stock - MarketBeat
Dir Larson-Green Sells 47,997 ($128.3K) Of Health Catalyst Inc [HCAT] - TradingView — Track All Markets
Health Catalyst's Market Cap Drops To US$190m Leaving Insiders With Losses - simplywall.st
What technical patterns form on Health Catalyst Inc. (2YP) stock chartsWeekly Market Outlook & Precise Buy Zone Tips - Newser
How Health Catalyst Inc. (2YP) stock behaves in tightening cyclesLong Setup & Weekly Market Pulse Alerts - Newser
Is Health Catalyst Inc. (2YP) stock positioned for digital growth era2025 Market Overview & Fast Moving Stock Watchlists - Newser
Health Catalyst, Inc. (NASDAQ:HCAT) Given Average Recommendation of "Hold" by Analysts - MarketBeat
Is Health Catalyst Inc. (2YP) stock supported by free cash flowWeekly Investment Summary & Stock Timing and Entry Methods - Newser
Why Health Catalyst Inc stock is a must watch in 2025 - BỘ NỘI VỤ
Health Catalyst, Inc (HCAT) Stock Analysis: Exploring a 45% Potential Upside Amidst Challenging Metrics - DirectorsTalk Interviews
Officer Freeman Surrenders 16,401 Of Health Catalyst Inc [HCAT] - TradingView
Will Health Catalyst Inc. (2YP) stock sustain bullish trend into 20252025 Technical Overview & Weekly High Return Forecasts - Newser
Health Catalyst appoints largest shareholder’s CEO to board By Investing.com - Investing.com Canada
Is Health Catalyst Inc. (2YP) stock expanding market penetrationJuly 2025 Summary & Real-Time Volume Analysis Alerts - Newser
Can Health Catalyst Inc. (2YP) stock sustain breakout momentumJuly 2025 Earnings & Daily Stock Trend Reports - Newser
Health Catalyst Q3 2025 Earnings Preview - MSN
Matt Arens, CEO and founder of Health Catalyst's largest shareholder, First Light Asset Management, joins board of directors - marketscreener.com
Matt Arens, CEO And Founder Of Health Catalyst's Largest Shareholder, First Light Asset Management, Joins Board Of Directors - TradingView
Health Catalyst appoints largest shareholder’s CEO to board - Investing.com
Health Catalyst Appoints New Board Member Matt Arens - TipRanks
Health Catalyst Appoints Matt Arens to Board of Directors - TradingView — Track All Markets
Matt Arens, CEO and Founder of Health Catalyst's Largest Shareholder, First Light Asset Management, Joins Board of Directors - PR Newswire
Health Catalyst Inc Azioni (HCAT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Health Catalyst Inc Azioni (HCAT) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Larson-Green Julie | Director |
Dec 04 '25 |
Sale |
2.67 |
47,997 |
128,349 |
73,573 |
6.07%
0.99%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):